No abstract available
MeSH terms
-
Adverse Drug Reaction Reporting Systems
-
Cardiovascular Diseases / mortality*
-
Clinical Trials, Phase IV as Topic
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Drug Approval / legislation & jurisprudence*
-
Humans
-
Hypoglycemic Agents / adverse effects*
-
Meta-Analysis as Topic
-
Myocardial Infarction / chemically induced*
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
Rosiglitazone
-
Thiazolidinediones / adverse effects*
-
United States
-
United States Food and Drug Administration
Substances
-
Hypoglycemic Agents
-
Thiazolidinediones
-
Rosiglitazone